Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$370 Mln
P/E Ratio
--
P/B Ratio
2.29
Industry P/E
--
Debt to Equity
0.05
ROE
-0.82 %
ROCE
-73.69 %
Div. Yield
0 %
Book Value
2.31
EPS
-2.32
CFO
$-339.94 Mln
EBITDA
$-373.92 Mln
Net Profit
$-375.34 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
COMPASS Pathways (CMPS)
| -0.26 | 28.23 | -4.31 | -52.52 | -26.57 | -- | -- |
|
BSE Sensex*
| 2.55 | 3.65 | 4.54 | 7.46 | 12.04 | 19.65 | 11.41 |
|
2024
|
2023
|
2022
|
2021
|
|
|---|---|---|---|---|
|
COMPASS Pathways (CMPS)
| -56.50 | 8.97 | -63.67 | -53.61 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 38.55 | 10,593.45 | 21.84 | 23.13 | |
| 306.35 | 8,570.17 | 22.78 | 66.44 | |
| 27.82 | 10,589.59 | -- | -28.77 | |
| 107.24 | 10,559.67 | 32.44 | 14.16 |
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of... treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom. Address: 33 Broadwick Street, London, United Kingdom, W1F 0DQ Read more
CEO & Director
Mr. Kabir Nath M.A., M.B.A.
CEO & Director
Mr. Kabir Kumar Nath M.A., M.B.A.
Headquarters
London
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of COMPASS Pathways Plc (CMPS) stood at $ 214 Mln as on 31-Dec-24
The share price of COMPASS Pathways Plc (CMPS) is $3.77 (NASDAQ) as of 29-Apr-2025 16:00 EDT. COMPASS Pathways Plc (CMPS) has given a return of -26.57% in the last 3 years.
COMPASS Pathways Plc (CMPS) has a market capitalisation of $ 370 Mln as on 29-Apr-2025. As per Value Research classification, it is a company.
Since, TTM earnings of COMPASS Pathways Plc (CMPS) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the COMPASS Pathways Plc (CMPS) and enter the required number of quantities and click on buy to purchase the shares of COMPASS Pathways Plc (CMPS).
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom. Address: 33 Broadwick Street, London, United Kingdom, W1F 0DQ
The CEO & director of Mr. Kabir Nath M.A., M.B.A.. is COMPASS Pathways Plc (CMPS), and CFO & Sr. VP is Mr. Kabir Kumar Nath M.A., M.B.A..
There is no promoter pledging in COMPASS Pathways Plc (CMPS).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,014
|
|
|
1,003
|
|
|
956
|
|
|
867
|
| COMPASS Pathways Plc (CMPS) | Ratios |
|---|---|
|
Return on equity(%)
|
-81.55
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
--
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of COMPASS Pathways Plc (CMPS) was $0 Mln.
$-0.11
(
